Literature DB >> 23970103

SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase.

Murilo T D Bueno1, Stéphane Richard1.   

Abstract

The histone lysine demethylase KDM5B plays key roles in gene repression by demethylating trimethylated lysine 4 of histone H3 (H3K4me3), a modification commonly found at the promoter region of actively transcribed genes. KDM5B is known to regulate the expression of genes involved in cell cycle progression; however, little is known about the post-translational modifications that regulate KDM5B. Herein, we report that KDM5B is SUMOylated at lysine residues 242 and 278 and that the ectopic expression of the hPC2 SUMO E3 ligase enhances this SUMOylation. Interestingly, the levels of KDM5B and its SUMOylated forms are regulated during the cell cycle. KDM5B is modulated by RNF4, an E3 ubiquitin ligase that targets SUMO-modified proteins to proteasomal degradation. Digital gene expression analyses showed that cells expressing the SUMOylation-deficient KDM5B harbor repressed mRNA expression profiles of cell cycle and DNA repair genes. Chromatin immunoprecipitations confirmed some of these genes as KDM5B targets, as they displayed reduced H3K4me3 levels in cells ectopically expressing KDM5B. We propose that SUMOylation by hPC2 regulates the activity of KDM5B.

Entities:  

Keywords:  KDM5B; RNF4; SUMOylation; gene occupancy; hPC2; lysine demethylase; lysine methylation

Mesh:

Substances:

Year:  2013        PMID: 23970103     DOI: 10.4161/epi.26112

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  18 in total

Review 1.  JARID1 Histone Demethylases: Emerging Targets in Cancer.

Authors:  Kayla M Harmeyer; Nicole D Facompre; Meenhard Herlyn; Devraj Basu
Journal:  Trends Cancer       Date:  2017-09-12

2.  A comprehensive compilation of SUMO proteomics.

Authors:  Ivo A Hendriks; Alfred C O Vertegaal
Journal:  Nat Rev Mol Cell Biol       Date:  2016-07-20       Impact factor: 94.444

3.  SUMO-2 Orchestrates Chromatin Modifiers in Response to DNA Damage.

Authors:  Ivo A Hendriks; Louise W Treffers; Matty Verlaan-de Vries; Jesper V Olsen; Alfred C O Vertegaal
Journal:  Cell Rep       Date:  2015-03-12       Impact factor: 9.423

4.  SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.

Authors:  Wenfu Lu; Shenji Liu; Bo Li; Yingqiu Xie; Christine Adhiambo; Qing Yang; Billy R Ballard; Keiichi I Nakayama; Robert J Matusik; Zhenbang Chen
Journal:  Oncotarget       Date:  2015-01-20

Review 5.  Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.

Authors:  Zhenbang Chen; Wenfu Lu
Journal:  Int J Mol Sci       Date:  2015-02-27       Impact factor: 5.923

6.  Whole exome sequencing in females with autism implicates novel and candidate genes.

Authors:  Merlin G Butler; Syed K Rafi; Waheeda Hossain; Dietrich A Stephan; Ann M Manzardo
Journal:  Int J Mol Sci       Date:  2015-01-07       Impact factor: 5.923

Review 7.  Therapeutic targeting of the hypoxic tumour microenvironment.

Authors:  Dean C Singleton; Andrew Macann; William R Wilson
Journal:  Nat Rev Clin Oncol       Date:  2021-07-29       Impact factor: 66.675

Review 8.  Arsenic-induced epigenetic changes in cancer development.

Authors:  Wesley N Saintilnord; Yvonne Fondufe-Mittendorf
Journal:  Semin Cancer Biol       Date:  2021-03-30       Impact factor: 15.707

Review 9.  SUMO-Targeted Ubiquitin Ligases and Their Functions in Maintaining Genome Stability.

Authors:  Ya-Chu Chang; Marissa K Oram; Anja-Katrin Bielinsky
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

Review 10.  Hypoxia-Inducible Histone Lysine Demethylases: Impact on the Aging Process and Age-Related Diseases.

Authors:  Antero Salminen; Kai Kaarniranta; Anu Kauppinen
Journal:  Aging Dis       Date:  2016-03-15       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.